Autoimmune screening panel in patients with multiple sclerosis: A Vienna multiple sclerosis database study
The rate of ASP seropositivity in MS is low and within the range of the general population. Performance of ASPs without clinical suspicion of systemic autoimmune disease seems unwarranted.
Authors
- Barbara Kornek (ORCID: https://orcid.org/0000-0002-1851-6967)
- Paulus Stefan Rommer (ORCID: https://orcid.org/0000-0001-5209-6647)
- Gabriel Bsteh (ORCID: https://orcid.org/0000-0002-0825-0851)
- Christiane Schmied
- Markus Ponleitner (ORCID: https://orcid.org/0000-0002-3709-1845)
- Katharina Alina Riedl (ORCID: https://orcid.org/0000-0001-5956-0051)
- Nik Krajnc (ORCID: https://orcid.org/0000-0002-4146-5870)
- Karin Zebenholzer (ORCID: https://orcid.org/0000-0001-6930-019X)
- Thomas Berger (ORCID: https://orcid.org/0000-0002-2062-5193)
- Fritz Leutmezer (ORCID: https://orcid.org/0000-0001-5665-8635)
- Tobias Zrzavy (ORCID: https://orcid.org/0000-0001-8909-1591)
- Gudrun Zulehner (ORCID: https://orcid.org/0000-0003-4151-684X)
- Stefan Macher (ORCID: https://orcid.org/0000-0001-8068-1528)
- Fabian Föttinger (ORCID: https://orcid.org/0009-0005-7970-5349)
Institutions
- Medical University of Vienna (AT)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1111/ene.16558
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.42